Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
39.22 USD -1.08 ( 2.68%)
Last update at 2026-11-03T20:56:00Z
VOLUME
423
Market Cap
59135.56M
P/E
20.12

Momentum Score

…

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
39.22
Low
39.22
High
52 Week Price Range
26.22
Low
47.61
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

RELX plc is a global provider of information and analytics for professional and business customers across scientific, legal, risk and exhibitions markets. Its long-term growth may be driven by digital subscription conversion, expansion of data and analytics offerings and AI-enabled services, and investors may find its diversified, high-margin, cash-generative subscription model attractive.
Key risks include regulatory and antitrust scrutiny in publishing and data services, pressure from open-access and alternative content providers, cyclicality and event-risk in exhibitions, and exposure to data-privacy rules and currency fluctuations.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
40.30
Dividend Yield
1.94%
Revenue TTM
9720.00M
Revenue Per Share
5.38
Gross Profit TTM
6456.00M
Debt / Equity
3.10
ROE
131.86%
Net Debt
7201.83M
ROCE
34.78%
Diluted EPS TTM
1.69

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 2749.55M 2557.00M 2295.00M 2113.00M 1797.00M
Minority interest -13.00M -10.00M -7.00M 2.00M 0.00M
Net income 2064.67M 1934.00M 1781.00M 1634.00M 1471.00M
Selling general administrative 1863.00M 1846.00M 1850.00M 1819.00M 1630.00M
Selling and marketing expenses 1511.00M 1470.00M 1459.00M 1385.00M 1197.00M
Gross profit 6108.01M 6134.00M 5945.00M 5508.00M 4682.00M
Reconciled depreciation 663.00M 706.00M 717.00M 713.00M 724.00M
Ebit 3047.51M 2817.00M 2595.00M 2327.00M 1892.00M
Ebitda 3799.38M 3047.00M 3312.00M 3040.00M 2616.00M
Depreciation and amortization 751.88M 230.00M 717.00M 713.00M 724.00M
Operating income 2982.52M 2861.00M 2682.00M 2323.00M 1884.00M
Other operating expenses 6605.93M 6573.00M 6479.00M 6249.00M 5389.00M
Interest expense 297.95M 281.00M 300.00M 205.00M 150.00M
Tax provision 672.00M 613.00M 507.00M 481.00M 326.00M
Interest income 12.00M 6.00M 8.00M 4.00M 8.00M
Net interest income -258.00M -276.00M -293.00M -201.00M -142.00M
Income tax expense 671.89M 613.00M 507.00M 481.00M 326.00M
Total revenue 9588.45M 9434.00M 9161.00M 8553.00M 7244.00M
Total operating expenses 3125.49M 3273.00M 3263.00M 3204.00M 2827.00M
Cost of revenue 3480.44M 3300.00M 3216.00M 3045.00M 2562.00M
Total other income expense net -232.96M -304.00M -387.00M -210.00M -87.00M
Net income from continuing ops 2078.00M 1944.00M 1788.00M 1632.00M 1471.00M
Net income applicable to common shares - - - 1634.00M 1471.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 14754.61M 15133.00M 14917.00M 15829.00M 13858.00M
Intangible assets 3071.50M 3164.00M 3238.00M 3524.00M 3304.00M
Other current assets 49.99M 79.00M 372.00M 21.00M 31.00M
Total liab 12365.00M 11629.00M 11478.00M 12075.00M 10634.00M
Total stockholder equity 2365.62M 3481.00M 3460.00M 3776.00M 3232.00M
Other current liab 161.97M 3783.00M 3843.00M 300.00M 241.00M
Common stock 263.96M 272.00M 275.00M 279.00M 286.00M
Capital stock 264.00M 272.00M 275.00M 279.00M 286.00M
Other liab - - - 1028.00M 944.00M
Good will 7928.71M 8216.00M 8023.00M 8388.00M 7366.00M
Other assets - - - 291.00M 327.00M
Cash 130.98M 119.00M 155.00M 334.00M 113.00M
Total current liabilities 5992.03M 5718.00M 5490.00M 5187.00M 3748.00M
Current deferred revenue - - 163.00M - -
Net debt 7201.83M 6425.00M 6342.00M 6396.00M 6054.00M
Short term debt 1600.75M 1412.00M 1313.00M 870.00M 232.00M
Short long term debt 1541.00M 1374.00M 1256.00M 803.00M 163.00M
Short long term debt total 7332.81M 6544.00M 6497.00M 6730.00M 6167.00M
Other stockholder equity 1972.68M 3209.00M 3185.00M 3497.00M 2946.00M
Property plant equipment - - - 271.00M 292.00M
Total current assets 2959.52M 2996.00M 2874.00M 3069.00M 2357.00M
Net tangible assets - - - -8136.00M -7438.00M
Short term investments - - 48.00M - -
Net receivables 2467.60M 2467.00M 2029.00M 2405.00M 1644.00M
Long term debt 5629.00M 5067.00M 5100.00M 5745.00M 5796.00M
Inventory 310.95M 331.00M 318.00M 309.00M 253.00M
Accounts payable 4259.31M 223.00M 171.00M 4017.00M 3275.00M
Accumulated other comprehensive income 128.98M 2326.00M 2180.00M - -
Non currrent assets other 196.97M 325.00M 295.00M 431.00M 329.00M
Non current assets total 11795.09M 12137.00M 12043.00M 12760.00M 11501.00M
Capital lease obligations 97.00M 103.00M 141.00M 182.00M 208.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -42.00M -575.00M -569.00M -859.00M -8.00M
Change to liabilities - - - 280.00M -32.00M
Total cashflows from investing activities -828.87M - - -859.00M -384.00M
Net borrowings 736.00M - - 182.00M -724.00M
Total cash from financing activities -2031.67M -2065.00M -2057.00M -1334.00M -1606.00M
Change to operating activities - - - - -148.00M
Net income 2064.67M 1934.00M 1781.00M 2323.00M 1884.00M
Change in cash 20.49M -36.00M -179.00M 221.00M 25.00M
Begin period cash flow 110.49M 155.00M 334.00M 113.00M 88.00M
End period cash flow 130.98M 119.00M 155.00M 334.00M 113.00M
Total cash from operating activities 2875.53M 2608.00M 2457.00M 2401.00M 2016.00M
Issuance of capital stock -34.00M -28.00M 41.00M 26.00M 32.00M
Depreciation 751.88M 783.00M 717.00M 713.00M 724.00M
Other cashflows from investing activities -464.00M -385.00M -419.00M 33.00M 20.00M
Dividends paid 1180.81M 1121.00M 1059.00M 983.00M 920.00M
Change to inventory -100.98M -83.00M -90.00M -103.00M -13.00M
Change to account receivables 14.00M - -24.00M -251.00M -103.00M
Sale purchase of stock -1575.74M -1000.00M -800.00M -550.00M -1.00M
Other cashflows from financing activities -54.99M 453.00M -77.00M 309.00M -172.00M
Change to netincome - - - 56.00M -31.00M
Capital expenditures 21.00M 20.00M 477.00M 436.00M 337.00M
Change in working capital -62.99M -146.00M -114.00M -74.00M -148.00M
Stock based compensation 63.00M 66.00M 56.00M 46.00M 45.00M
Other non cash items 58.98M -29.00M 17.00M -607.00M -489.00M
Free cash flow 2854.54M 2588.00M 1980.00M 1965.00M 1679.00M

Peer Comparison*

Sector: Industrials Industry: Specialty Business Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RLXXF
Relx PLC
-1.08
2.68%
39.22 20.12 15.38 6.08 35.32 5.43 13.82
CTAS
Cintas Corporation
-
-%
223.74 37.19 33.11 6.39 14.93 6.73 24.37
RELX
Relx PLC ADR
-1.06
2.62%
39.40 20.25 16.16 6.12 37.10 5.55 14.13
TRI
Thomson Reuters Corporation Common Shares
-12.06
9.87%
110.18 27.00 20.92 5.68 4.12 6.20 14.50
WTKWY
Wolters Kluwer NV
-2.29
2.34%
95.57 30.98 26.45 6.17 15.44 6.64 21.22

Profile*

Relx PLC

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

1-3 Strand, London, United Kingdom, WC2N 5JR

44 20 7166 5500

37000

Name Title Year Born
Mr. Erik Engstrom CEO & Exec. Director 1963
Mr. Nicholas Lawrence Luff CFO & Exec. Director 1967
Ms. Kumsal Bayazit Besson Chief Exec. Officer of Scientific, Technical & Medical 1974
Mr. Colin Tennant Head of Investor Relations NA
Mr. Henry Adam Udow Chief Legal Officer & Company Sec. 1958
Mr. Paul Abrahams Head of Corp. Communications NA
Ms. Rosemary Thomson Chief HR Officer 1969
Mr. Mark Kelsey Chief Exec. Officer of Risk NA
Ms. Jelena Sevo Chief Strategy Officer NA
Mr. Michael Walsh Chief Exec. Officer of Legal NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…